Cargando…

Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy

PURPOSE: The aim of the study was to exploit the feasibility of thermoluminescent dosimeters (TLDs) in radiation therapy techniques in which high dose per fraction is involved. METHODS: Dose–response of TLD-100 (LiF: Mg, Ti) was investigated in both 6-MV photon and 6-MeV electron beams. The element...

Descripción completa

Detalles Bibliográficos
Autores principales: Liuzzi, Raffaele, Piccolo, Consiglia, D’Avino, Vittoria, Clemente, Stefania, Oliviero, Caterina, Cella, Laura, Pugliese, Mariagabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019407/
https://www.ncbi.nlm.nih.gov/pubmed/32110167
http://dx.doi.org/10.1177/1559325819894081
_version_ 1783497517952925696
author Liuzzi, Raffaele
Piccolo, Consiglia
D’Avino, Vittoria
Clemente, Stefania
Oliviero, Caterina
Cella, Laura
Pugliese, Mariagabriella
author_facet Liuzzi, Raffaele
Piccolo, Consiglia
D’Avino, Vittoria
Clemente, Stefania
Oliviero, Caterina
Cella, Laura
Pugliese, Mariagabriella
author_sort Liuzzi, Raffaele
collection PubMed
description PURPOSE: The aim of the study was to exploit the feasibility of thermoluminescent dosimeters (TLDs) in radiation therapy techniques in which high dose per fraction is involved. METHODS: Dose–response of TLD-100 (LiF: Mg, Ti) was investigated in both 6-MV photon and 6-MeV electron beams. The element correction factor (ECF) generation method was applied to check the variability of the TLDs response. Two batches of 50 TLDs were divided into groups and exposed in the dose range 0 to 30 Gy. Regression analysis was performed with both linear and quadratic models. For each irradiation beam, the calibration curves were obtained in 3 dose range 0 to 8 Gy, 0 to 10 Gy, and 0 to 30 Gy. The best-fitting model was assessed by the Akaike Information Criterion test. RESULTS: The ECF process resulted a useful tool to reduce the coefficients of variation from original values higher than 5% to about 3.5%, for all the batches exposed. The results confirm the linearity of dose–response curve below the dose level of 10 Gy for photon and electron beam and the supralinear trend above. CONCLUSION: The TLDs are suitable dosimeters for dose monitoring and verification in radiation treatment involving dose up to 30 Gy in a single fraction.
format Online
Article
Text
id pubmed-7019407
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-70194072020-02-27 Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy Liuzzi, Raffaele Piccolo, Consiglia D’Avino, Vittoria Clemente, Stefania Oliviero, Caterina Cella, Laura Pugliese, Mariagabriella Dose Response Original Article PURPOSE: The aim of the study was to exploit the feasibility of thermoluminescent dosimeters (TLDs) in radiation therapy techniques in which high dose per fraction is involved. METHODS: Dose–response of TLD-100 (LiF: Mg, Ti) was investigated in both 6-MV photon and 6-MeV electron beams. The element correction factor (ECF) generation method was applied to check the variability of the TLDs response. Two batches of 50 TLDs were divided into groups and exposed in the dose range 0 to 30 Gy. Regression analysis was performed with both linear and quadratic models. For each irradiation beam, the calibration curves were obtained in 3 dose range 0 to 8 Gy, 0 to 10 Gy, and 0 to 30 Gy. The best-fitting model was assessed by the Akaike Information Criterion test. RESULTS: The ECF process resulted a useful tool to reduce the coefficients of variation from original values higher than 5% to about 3.5%, for all the batches exposed. The results confirm the linearity of dose–response curve below the dose level of 10 Gy for photon and electron beam and the supralinear trend above. CONCLUSION: The TLDs are suitable dosimeters for dose monitoring and verification in radiation treatment involving dose up to 30 Gy in a single fraction. SAGE Publications 2020-02-13 /pmc/articles/PMC7019407/ /pubmed/32110167 http://dx.doi.org/10.1177/1559325819894081 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Liuzzi, Raffaele
Piccolo, Consiglia
D’Avino, Vittoria
Clemente, Stefania
Oliviero, Caterina
Cella, Laura
Pugliese, Mariagabriella
Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy
title Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy
title_full Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy
title_fullStr Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy
title_full_unstemmed Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy
title_short Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy
title_sort dose–response of tld-100 in the dose range useful for hypofractionated radiotherapy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019407/
https://www.ncbi.nlm.nih.gov/pubmed/32110167
http://dx.doi.org/10.1177/1559325819894081
work_keys_str_mv AT liuzziraffaele doseresponseoftld100inthedoserangeusefulforhypofractionatedradiotherapy
AT piccoloconsiglia doseresponseoftld100inthedoserangeusefulforhypofractionatedradiotherapy
AT davinovittoria doseresponseoftld100inthedoserangeusefulforhypofractionatedradiotherapy
AT clementestefania doseresponseoftld100inthedoserangeusefulforhypofractionatedradiotherapy
AT olivierocaterina doseresponseoftld100inthedoserangeusefulforhypofractionatedradiotherapy
AT cellalaura doseresponseoftld100inthedoserangeusefulforhypofractionatedradiotherapy
AT pugliesemariagabriella doseresponseoftld100inthedoserangeusefulforhypofractionatedradiotherapy